Naproxen Sodium/Pseudoephedrine Hydrochloride

萘普生钠/盐酸伪麻黄碱

Report date: 2022/08/16 20:00:19

Base Information

Drug NameNaproxen Sodium/Pseudoephedrine Hydrochloride
Drug Alias Name盐酸伪麻黄碱萘普生钠Naproxen Sodium and Pseudoephedrine萘普生钠盐酸伪麻黄碱Pseudoephedrine and Naproxen SodiumPseudoephedrine/Naproxen Sodium +[8] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAlpha adrenergic receptor agonists
TargetsAlpha adrenergic receptorCyclooxygenases
Therapy Area/IndicationsPainFeverNasal Obstruction +[4] 
Global Approved IndicationsPainFeverNasal Obstruction +[4] 
Approved Indications in ChinaPainFeverNasal Obstruction +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1999/11/29
Country/TerritoryUnited StatesMainland China
CombinationsYes Pseudoephedrine HydrochlorideNaproxen
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Sixth Pharmaceutical Factory
Inactive CompaniesBayer AG
Active IndicationsPainFeverNasal Obstruction +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksN/A